SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Wegovy
Wegovy
Page 6 of 6
Finance
Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot
By
Paula Doenecke
and
Bloomberg
December 4, 2023
Health
Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro
By
Madison Muller
and
Bloomberg
December 1, 2023
Health
Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs
By
Prarthana Prakash
November 27, 2023
Health
Obesity drugs in Ozempic, Wegovy and Mounjaro are trimming back the Thanksgiving ‘food orgy’
By
Jonel Aleccia
and
The Associated Press
November 20, 2023
Retail
So many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug
By
Ryan Hogg
November 16, 2023
Retail
Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports
By
Prarthana Prakash
November 13, 2023
Health
A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’
By
Madison Muller
,
Naomi Kresge
and
Bloomberg
November 11, 2023
Retail
Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
By
Ryan Hogg
November 9, 2023
Health
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By
Ryan Hogg
November 6, 2023
Health
Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By
Prarthana Prakash
November 3, 2023
Health
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By
Ryan Hogg
November 2, 2023
KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories
By
Ryan Hogg
October 19, 2023
Finance
Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By
Prarthana Prakash
October 10, 2023
Most Popular
Commentary
My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
By
Brian Walsh
Success
AI expert says it’s ‘not a question’ that AI will take over all jobs—but people will have 80 hours a week of free time
By
Emma Burleigh
Success
Workday’s CEO says his career took off after he changed his attitude—and Amazon boss Andy Jassy swears by the same...
By
Preston Fore